切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2021, Vol. 10 ›› Issue (03) : 231 -234. doi: 10.3877/cma.j.issn.2095-3232.2021.03.001

所属专题: 文献

述评

浅谈肝细胞癌伴胆管癌栓的手术治疗现状及争议
冯锦凯1, 陈振华2, 武宇轩3, 程树群1,()   
  1. 1. 200438 上海,海军军医大学东方肝胆外科医院肝外六科
    2. 310052 杭州,武警部队浙江省总队医院普外科
    3. 200433 上海,海军军医大学基础医学院学员四大队十队
  • 收稿日期:2021-03-18 出版日期:2021-06-10
  • 通信作者: 程树群
  • 基金资助:
    国家自然科学基金重点项目(81730097)

Current situation and controversies on surgical treatments for hepatocellular carcinoma with bile duct tumor thrombus

Jinkai Feng1, Zhenhua Chen2, Yuxuan Wu3   

  • Received:2021-03-18 Published:2021-06-10
引用本文:

冯锦凯, 陈振华, 武宇轩, 程树群. 浅谈肝细胞癌伴胆管癌栓的手术治疗现状及争议[J]. 中华肝脏外科手术学电子杂志, 2021, 10(03): 231-234.

Jinkai Feng, Zhenhua Chen, Yuxuan Wu. Current situation and controversies on surgical treatments for hepatocellular carcinoma with bile duct tumor thrombus[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2021, 10(03): 231-234.

[1]
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394-424.
[2]
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132.
[3]
Wang DD, Wu LQ, Wang ZS. Prognosis of hepatocellular carcinoma with bile duct tumor thrombus after R0 resection: a matched study[J]. Hepatobiliary Pancreat Dis Int, 2016, 15(6):626-632.
[4]
An J, Lee KS, Kim KM, et al. Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion[J]. Clin Mol Hepatol, 2017, 23(2):160-169.
[5]
Luo X, Tan W, Yi B, et al. Surgery of hepatocellular carcinoma complicated with cancer thrombi in bile duct: efficacy for criteria for different therapy modalities[J]. Langenbecks Arch Surg, 2009, 394(6):1033-1039.
[6]
Oba A, Takahashi S, Kato Y, et al. Usefulness of resection for hepatocellular carcinoma with macroscopic bile duct tumor thrombus[J]. Anticancer Res, 2014, 34(8): 4367-4372.
[7]
Wong TC, Cheung TT, Chok KS, et al. Outcomes of hepatectomy for hepatocellular carcinoma with bile duct tumour thrombus[J]. HPB, 2015, 17(5):401-408.
[8]
Kim JM, Kwon CH, Joh JW, et al. Incidental microscopic bile duct tumor thrombi in hepatocellular carcinoma after curative hepatectomy: a matched study[J]. Medicine, 2015, 94(6):e450.
[9]
Orimo T, Kamiyama T, Yokoo H, et al. Hepatectomy for hepatocellular carcinoma with bile duct tumor thrombus, including cases with obstructive jaundice[J]. Ann Surg Oncol, 2016, 23(8):2627-2634.
[10]
Pang YB, Zhong JH, Luo XL, et al. Clinicopathological characteristics and liver stem cell marker expression in hepatocellular carcinoma involving bile duct tumor thrombi[J]. Tumour Biol, 2016, 37(5):5879-5884.
[11]
Yang X, Qiu Z, Ran R, et al. Prognostic importance of bile duct invasion in surgical resection with curative intent for hepatocellular carcinoma using PSM analysis[J]. Oncol Lett, 2018, 16(3):3593-3602.
[12]
Qiao W, Yu F, Wu L, et al. Surgical outcomes of hepatocellular carcinoma with biliary tumor thrombus: a systematic review[J]. BMC Gastroenterol, 2016(16):11.
[13]
Navadgi S, Chang CC, Bartlett A, et al. Systematic review and meta-analysis of outcomes after liver resection in patients with hepatocellular carcinoma (HCC) with and without bile duct thrombus[J]. HPB, 2016, 18(4):312-316.
[14]
Meng KW, Dong M, Zhang WG, et al. Clinical characteristics and surgical prognosis of hepatocellular carcinoma with bile duct invasion[J]. Gastroenterol Res Pract, 2014:604971.
[15]
Wang C, Yang Y, Sun D, et al. Prognosis of hepatocellular carcinoma patients with bile duct tumor thrombus after hepatic resection or liver transplantation in Asian populations: a meta-analysis[J]. PLoS One, 2017, 12(5):e0176827.
[16]
Noda T, Nagano H, Tomimaru Y, et al. Prognosis of hepatocellular carcinoma with biliary tumor thrombi after liver surgery[J]. Surgery, 2011, 149(3):371-377.
[17]
Hu XG, Mao W, Hong SY, et al. Surgical treatment for hepatocellular carcinoma with bile duct invasion[J]. Ann Surg Treat Res, 2016, 90(3):139-146.
[18]
Kim DS, Kim BW, Hatano E, et al. Surgical outcomes of hepatocellular carcinoma with bile duct tumor thrombus: a Korea-Japan multicenter study[J]. Ann Surg, 2020, 271(5):913-921.
[19]
Kasai Y, Hatano E, Seo S, et al. Hepatocellular carcinoma with bile duct tumor thrombus: surgical outcomes and the prognostic impact of concomitant major vascular invasion[J]. World J Surg, 2015, 39(6): 1485-1493.
[20]
Yamamoto S, Hasegawa K, Inoue Y, et al. Bile duct preserving surgery for hepatocellular carcinoma with bile duct tumor thrombus[J]. Ann Surg, 2015, 261(5):e123-125.
[21]
Woo S, Chung JW, Hur S, et al. Liver abscess after transarterial chemoembolization in patients with bilioenteric anastomosis: frequency and risk factors[J]. AJR Am J Roentgenol, 2013, 200(6): 1370-1377.
[22]
Hoffmann R, Rempp H, Schmidt D, et al. Prolonged antibiotic prophylaxis in patients with bilioenteric anastomosis undergoing percutaneous radiofrequency ablation[J]. J Vasc Interv Radiol, 2012, 23(4):545-551.
[23]
Zeng H, Xu LB, Wen JM, et al. Hepatocellular carcinoma with bile duct tumor thrombus: a clinicopathological analysis of factors predictive of recurrence and outcome after surgery[J]. Medicine, 2015, 94(1):e364.
[24]
Xu LB, Liu C. Hepatocellular carcinoma with bile duct tumor thrombus: extrahepatic bile duct preserving or not?[J]. Ann Surg, 2017, 266(6):e62-63.
[25]
Moon DB, Hwang S, Wang HJ, et al. Surgical outcomes of hepatocellular carcinoma with bile duct tumor thrombus: a Korean multicenter study[J]. World J Surg, 2013, 37(2):443-451.
[26]
Shi X, Fu H, Ruan T, et al. Meta-analysis of concurrent hepatectomy with extrahepatic bile duct resection in hepatocellular carcinoma patients with bile duct tumor thrombi[J]. HPB, 2019(21):S993.
[1] 姚宏伟, 魏鹏宇, 高加勒, 张忠涛. 不断提高腹腔镜右半结肠癌D3根治术的规范化[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 1-4.
[2] 杜晓辉, 崔建新. 腹腔镜右半结肠癌D3根治术淋巴结清扫范围与策略[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 5-8.
[3] 张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[4] 杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[5] 冯冰, 邹秋果, 梁振波, 卢艳明, 曾奕, 吴淑苗. 老年非特殊型浸润性乳腺癌超声征象与分子生物学指标的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 48-51.
[6] 栗艳松, 冯会敏, 刘明超, 刘泽鹏, 姜秋霞. STIP1在三阴性乳腺癌组织中的表达及临床意义研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 52-56.
[7] 钱龙, 陆晓峰, 王行舟, 杜峻峰, 沈晓菲, 管文贤. 神经系统调控胃肠道肿瘤免疫应答研究进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 86-89.
[8] 叶晓琳, 刘云飞, 庞明泉, 王海久, 任利, 侯立朝, 于文昊, 王志鑫, 樊海宁. 肝再生细胞来源及调控机制的研究进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 96-99.
[9] 尚培中, 张润萍, 张伟, 贾国洪, 李晓武, 苗建军, 刘冰. 梗阻性黄疸临床防治新技术单中心应用研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 104-107.
[10] 彭旭, 邵永孚, 李铎, 邹瑞, 邢贞明. 结肠肝曲癌的诊断和外科治疗[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 108-110.
[11] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[12] 曹迪, 张玉茹. 经腹腔镜生物补片修补直肠癌根治术后盆底疝1例[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 115-116.
[13] 李永胜, 孙家和, 郭书伟, 卢义康, 刘洪洲. 高龄结直肠癌患者根治术后短期并发症及其影响因素[J]. 中华临床医师杂志(电子版), 2023, 17(9): 962-967.
[14] 程相阵. 腹茧症9例诊治分析并文献复习[J]. 中华临床医师杂志(电子版), 2023, 17(9): 968-971.
[15] 袁媛, 赵良平, 刘智慧, 张丽萍, 谭丽梅, 閤梦琴. 子宫内膜癌组织中miR-25-3p、PTEN的表达及与病理参数的关系[J]. 中华临床医师杂志(电子版), 2023, 17(9): 1016-1020.
阅读次数
全文


摘要